Media preparation systems

A prepared medium is a supersaturated compromise: forty to eighty components, some of which are barely soluble, some of which react with each other, and some of which decompose into things that inhibit the culture. The equipment in a preparation suite exists to move that mixture from powder to a sterile, characterised liquid at the bioreactor inlet without altering it on the way. Formulation and commercial media manufacture are separate subjects; this page is about the operation next door to the vessel.

Hydration is not simply stirring

Dry powder media wet unevenly. A poorly dispersed addition forms lumps whose outer layer gels and shields the interior, so material that looks dissolved is not, and the resulting solution is under-strength in whatever was trapped. Powder is therefore added into a moving vortex at a controlled rate rather than dumped in, and mixers are specified by their ability to draw powder down without entraining air.

Several components need conditions the final medium does not have. Tyrosine and cystine are poorly soluble at neutral pH and are commonly dissolved separately in alkali before addition; bicarbonate buffering depends on the carbon dioxide the vessel will supply, so the pH of the prepared medium is not the pH the culture will see. Order of addition matters because calcium and phosphate will precipitate if concentrated together, and a precipitate that forms in the tank blinds the filter downstream.

Filtration, and why 0.2 micron may not be enough

Sterile filtration at 0.2 µm is the standard barrier and it removes bacteria and fungi reliably. Mycoplasma are the exception: they lack a cell wall, are among the smallest self-replicating organisms known, and are deformable enough to pass a 0.2 µm membrane. Where mycoplasma risk is taken seriously — animal-derived components, or any process where a contamination would be undetected for days — the medium is filtered at 0.1 µm instead. The cost is throughput: the tighter membrane fouls faster on lipids, protein and undissolved residue, and a filter train is sized by fouling behaviour rather than by nominal flux. Adsorption is the quieter problem. Low-concentration components — growth factors, some vitamins, surfactant — bind to membrane and tubing surfaces, so what leaves the filter is not always what entered it, and that loss is why filter and flow-path materials are qualified rather than substituted freely.

Hold time is a stability claim

Prepared medium degrades in the tank. Glutamine hydrolyses spontaneously, releasing ammonium and cyclising to pyroglutamate; the rate rises with temperature and time, so a medium held warm arrives carrying an inhibitor the formulation never contained. Light causes the other well-documented decay: riboflavin photosensitisation generates peroxide and toxic tryptophan photoproducts, which is why preparation suites and hold vessels are shielded. Every hold time in a batch record is therefore a stability statement that had to be demonstrated for that formulation, not a scheduling convenience.

Single-use flow paths — a gamma-irradiated bag, mixer, filter and transfer set assembled as one closed unit — remove cleaning validation between products and remove the open transfer step. They import the material questions set out in single-use bioprocessing: the flow path is now a source of leachables into a fluid that will spend days feeding a culture.